IndraLab
Statements
reach
"Auranofin (Aur) inhibits proteasome associated deubiquitinases (DUBs) UCHL5 and USP14 rather than the 20S proteasome; inhibition of the proteasome associated DUBs is required for Aur induced cytotoxicity; and Aur selectively inhibits tumor growth in vivo and induces cytotoxicity in cancer cells from patients with acute myeloid leukemia [XREF_BIBR]."
reach
"In detail, Auranofin release from PCN224@Au down-regulated the deubiquitinating enzymes (e.g., CyclinB, USP14 and UCH37) and promoted the proteasomal substrate proteins (e.g., c-Jun and p21) accumulations via activating MAP3Ks, CDK and p53 pathways, which drove ubiquitinated target degradation by proteasome."
reach
"The loaded Auranofin in PCN224@Au could be released to down-regulate the deubiquitinating enzymes (e.g., CyclinB, USP14 and UCH37), blockade the deubiquitinating process and promote the accumulations of proteasomal substrate proteins (e.g., c-Jun and p21) to encourage proteasomal degradation of ubiquitinated target proteins."